EP Patent

EP1827537B1 — Medication delivery system with a detector for providing a signal indicative of an amount of an ejected dose of drug

Assigned to Novo Nordisk AS · Expires 2019-08-14 · 7y expired

What this patent protects

Patent listed against naloxone-hydrochloride.

Drugs covered by this patent

Patent Metadata

Patent number
EP1827537B1
Jurisdiction
EP
Classification
—
Expires
2019-08-14
Drug substance claim
No
Drug product claim
No
Assignee
Novo Nordisk AS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.